Nico Babaian
Entrepreneur-in-Residence, HealthTech
Nico is an Entrepreneur-in-Residence at Oxford Science Enterprises. He’s here on a mission to find and co-found a new HealthTech business, focused on using AI to better understand and improve how people think and feel.
He joined OSE in 2026, and brings extensive experience across technology, product development and venture creation. Most recently, Nico led the development of new mental health ventures at GSK, spanning wearables, human and AI coaching, and emerging modalities including psychobiotics and brainwave-driven XR.
Earlier in his career, he co-founded and led two companies, one of which was acquired by Canon Inc. He also led mobile product development at Skype during a period of rapid growth, helping to establish it as one of the most widely downloaded applications of its time.
Nico has co-authored five pending or granted patents. He holds a degree in English from Vanderbilt University.
WORK WITH US
Oxford researchers & innovators
Want your research to have real-world impact?
We partner with researchers and innovators across Oxford, Harwell and Culham to explore commercial potential, co-create ventures and build companies.
Investors
Interested in becoming an OSE shareholder?
We’ve raised over £850m from global investors keen to access Oxford’s diverse, world-leading science. Our shareholders don’t just back OSE – many also co-invest alongside us.
Co-investors
Looking to invest in Oxford’s most exciting spinouts?
We partner with specialist global investors to fund and scale our companies – from pre-seed to growth. Together, OSE and our co-investors have invested more than £3bn.